Summary
Aflac Incorporated (AFL) reported a significant year-over-year decline in net earnings for the first quarter of 2025, primarily driven by a substantial shift from net investment gains in the prior year to net investment losses in the current quarter. Net earnings were $29 million, or $0.05 per diluted share, compared to $1.9 billion, or $3.25 per diluted share, in the first quarter of 2024. This swing is largely attributable to mark-to-market movements in investments and derivatives, particularly a significant net investment loss of $963 million in Q1 2025 versus a net investment gain of $951 million in Q1 2024. Despite the sharp decline in reported net earnings, adjusted earnings, which exclude certain volatile investment and foreign currency impacts, were $906 million, or $1.66 per diluted share, a slight decrease from $961 million, or $1.66 per diluted share, in the prior year. The company's operations in Japan, Aflac Japan, continue to be the larger segment, though yen weakening impacted dollar-denominated results. Aflac U.S. showed modest growth in net earned premiums and maintained stable profitability. The company continued its share repurchase program, returning $900 million to shareholders in the quarter. Shareholders' equity saw an increase, largely due to positive impacts from changes in discount rate assumptions on insurance reserves, although offset by unrealized losses on investments and foreign currency translation. Investors should focus on the adjusted earnings and operational performance metrics, as the reported net earnings are heavily influenced by market volatility. The company's core insurance business, particularly in Japan, remains robust, demonstrating resilience despite challenging investment market conditions. The continued share buybacks signal management's confidence in the company's underlying financial health.
Financial Highlights
31 data points| Revenue | $3.40B |
| SG&A Expenses | $802.00M |
| Operating Expenses | $1.31B |
| Interest Expense | $49.00M |
| Net Income | $29.00M |
| EPS (Basic) | $0.05 |
| EPS (Diluted) | $0.05 |
| Shares Outstanding (Basic) | 544.71M |
| Shares Outstanding (Diluted) | 546.88M |
Key Highlights
- 1Net earnings for Q1 2025 significantly decreased to $29 million ($0.05/share) from $1.9 billion ($3.25/share) in Q1 2024, primarily due to a swing from net investment gains to net investment losses.
- 2Adjusted earnings were $906 million ($1.66/share), a slight decrease from $961 million ($1.66/share) in Q1 2024, indicating resilient underlying operational performance.
- 3Aflac Japan segment's pretax adjusted earnings decreased by 10.9% year-over-year, impacted by lower net earned premiums and adjusted net investment income, partially offset by lower benefits and claims.
- 4Aflac U.S. segment's pretax adjusted earnings saw a slight increase of 0.6% year-over-year, driven by higher net earned premiums and improved expense efficiency, which offset higher benefits and claims.
- 5The company repurchased $900 million of its common stock in Q1 2025, underscoring its commitment to returning capital to shareholders.
- 6Shareholders' equity increased to $26.3 billion ($48.55/share) at March 31, 2025, from $26.1 billion ($47.45/share) at December 31, 2024, boosted by favorable changes in discount rate assumptions on insurance reserves.
- 7The company maintains strong capital positions in both its Japanese and U.S. segments, with Aflac Japan's Solvency Margin Ratio (SMR) and Aflac U.S.'s Risk-Based Capital (RBC) ratio remaining robust.